• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Mixed-Methods ACTION Study Evaluates General Practitioners in German Cancer Aftercare

by
November 10, 2026
in Health
Reading Time: 6 mins read
0
Mixed-Methods ACTION Study Evaluates General Practitioners in German Cancer Aftercare

Mixed-Methods ACTION Study Evaluates General Practitioners in German Cancer Aftercare

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A multicenter health services research consortium led by investigators at Hannover Medical School has launched the research protocol for the ACTION project, an investigation structured to evaluate and optimize the role of general practitioners in oncological aftercare across Germany. With long-term cancer survivorship steadily expanding due to demographic changes and sustained clinical advances in early detection and multimodal oncology regimens, the demand for sustainable, coordinated, and interdisciplinary survivorship care has intensified nationwide. Post-treatment aftercare is clinically vital for detecting malignant recurrences and regional metastases at treatable stages, identifying and managing therapy-induced toxicities, and addressing persistent physical, social, and psychological distress. While national medical societies and multiple clinical practice guidelines—such as the S3 guidelines for breast and pancreatic malignancies—advise structured aftercare regimens that can incorporate outpatient primary care physicians alongside organ specialists and internists, the empirical distribution of clinical follow-up responsibilities across German outpatient sectors remains inconsistently characterized and poorly standardized.

The study protocol outlines a comprehensive thirty-month investigation funded by German Cancer Aid under grant number 70116960, spanning from November 2026 through April 2029 and formally registered in the German Clinical Trials Register under registration identifier DRKS00040034. Designed as a non-interventional, cross-sectional health services research project, ACTION combines secondary routine healthcare data analyses, statewide quantitative surveys of general practitioners and oncology specialists, guided patient interviews, and a national consensus-building consensus initiative. Primary care physicians often maintain decades-long therapeutic relationships with patients, reside within easy geographical reach, and coordinate comprehensive clinical records, making them well-situated to deliver low-threshold survivorship care. However, substantial barriers persist in routine practice, including physician administrative burdens, time constraints, perceived gaps in specialized oncological knowledge, and fragmented interprofessional communication between primary care practices and specialized cancer clinics, leaving patients frequently uncertain regarding which provider should address specific late complications or survivorship needs.

To provide empirical clarity, the research project is divided into two sequential methodological phases, the first of which concentrates on Lower Saxony as a representative state characterized by a balanced urban-rural infrastructure and diverse healthcare delivery environments. Phase one comprises four dedicated work packages designed to capture oncological aftercare patterns from administrative, medical, and personal perspectives. In work package 1a, the investigators will execute a retrospective quantitative secondary data linkage connecting clinical records from the Lower Saxony Clinical Cancer Registry with longitudinal statutory health insurance billing data from Allgemeine Ortskrankenkasse Lower Saxony.

The quantitative data analysis in work package 1a focuses specifically on adult patients diagnosed between 2021 and 2024 with three distinct tumor entities: breast cancer, stage II and stage III colorectal cancer, and malignant melanoma. These three entities were chosen because their respective S3 guidelines outline explicit, schedule-driven aftercare regimens, permitting rigorous comparisons between recommended surveillance and observed clinical attendance, while also reflecting conditions where outpatient primary care involvement is clinically appropriate. Eligible individuals must have maintained continuous statutory health insurance coverage with AOK Lower Saxony for at least one full year following their initial oncological diagnosis, generating follow-up monitoring intervals between two and five years through 2026. The unique health insurance identification number serves as a deterministic linking key between the cancer registry and billing records, allowing the investigators to reconcile clinical tumor stages with individual billing histories of inpatient, outpatient, and provider-specific surveillance services while strictly adhering to European data protection standards.

Complementing the administrative registry linkage, work package 1b and work package 1c conduct statewide cross-sectional surveys to capture the experiential perspectives of healthcare providers operating in Lower Saxony. Work package 1b targets approximately 5,223 general practitioners working in statutory primary care across the federal state, contacted through email and fax channels using contact databases maintained and updated with the Association of Statutory Health Insurance Physicians of Lower Saxony. Anticipating an initial response rate of approximately ten percent, or between 470 and 574 completed questionnaires, the web-based survey utilizes standardized instruments programmed in SoSciSurvey to measure primary care physicians’ clinical self-perceptions, current involvement in cancer surveillance, interprofessional coordination with oncologists, procedural barriers, and their utilization of physical aftercare passports.

Concurrently, work package 1c investigates specialized secondary care providers by surveying approximately 430 oncological specialists across Lower Saxony, encompassing registered office-based medical oncologists, hematologists, and clinical directors representing 160 specialized cancer centers certified in the Oncomap directory of the German Cancer Society. With an estimated response rate of fifteen percent yielding roughly 58 to 72 participating specialists, this survey assesses oncologists’ current collaborative routines with general practitioners, expectations regarding the division of surveillance responsibilities, communication practices, and practical assessments of standardized aftercare documentation tools. To maximize participation across clinical settings, outreach will be supported by professional organizations including the German Society for Hematology and Medical Oncology, the Association of Practicing Internal Oncologists in Lower Saxony, and the Comprehensive Cancer Center Lower Saxony. Survey responses will be anonymized and evaluated using descriptive frequency metrics to identify structural misalignments between primary care expectations and specialist demands.

To integrate the lived experiences of service recipients into the empirical evaluation, work package 1d deploys qualitative methodology to explore the perspectives of adult cancer survivors who have completed primary antitumor therapy. Investigators plan to conduct between 25 and 30 problem-centered, semi-structured interviews with patients recruited via a practice-based research network of approximately 260 primary care clinics, the outpatient oncology facilities at Hannover Medical School, patient advocacy organizations, and self-help groups. Guided interviews will be conducted via telephone or secure videoconferencing depending on participant preference, exploring patient expectations regarding general practitioner oversight, personal communication with specialists, continuity of psychosocial support, and familiarity with aftercare passports. Following verbatim transcription of audio recordings, textual data will be systematically categorized using content-structuring qualitative analysis in MAXQDA, while sociodemographic characteristics will be summarized descriptively in SPSS to contextualize participant trajectories across diverse cancer types and demographic backgrounds.

At the conclusion of the empirical investigations in Lower Saxony, the project team will synthesize the quantitative billing trends, physician survey responses, and qualitative patient narratives into an integrated evidence base that informs phase two of the study. Phase two transitions the project from regional observational assessment to national consensus-building, engaging broad networks of healthcare stakeholders to formulate practical guidelines for routine clinical implementation. In work package 2a, the consortium will convene an on-site expert workshop in Hanover bringing together approximately twenty invited experts representing primary care medicine, clinical oncology centers, professional societies, regional cancer counseling offices, the German Cancer Research Center, the Oncology Guidelines Program, and national patient advocacy networks. Guided by focus-group moderation principles, participants will divide into small working groups to review phase-one empirical findings, evaluate structural bottlenecks, and translate empirical insights into structured draft recommendations for shared oncological follow-up models.

The draft recommendations developed during the Hanover workshop will subsequently undergo formal consensus evaluation in work package 2b through a national, multi-round Delphi consensus process conducted via online questionnaires. Approximately thirty-five healthcare experts, chosen from the workshop cohort and wider national primary and oncological care networks, will evaluate each proposed recommendation across two to three sequential voting rounds using a four-point Likert scale measuring healthcare relevance and clinical practicability. Consensus is operationally defined as reaching at least seventy-five percent affirmative agreement among respondents; recommendations failing to reach this threshold will be revised using qualitative textual feedback from participant comments and submitted for reassessment in subsequent voting rounds. Any proposal that fails to achieve seventy-five percent agreement after three deliberative cycles will be excluded from the final consensus framework, ensuring that the resulting guideline reflects robust interdisciplinary agreement across inpatient and outpatient care sectors.

By uniting rigorous epidemiological data linkage with multi-perspective qualitative inquiry and national consensus methods, the ACTION project addresses fundamental data gaps surrounding the real-world execution of cancer survivorship care in Germany. Ethical oversight for the research program has been established through approval from the Ethics Committee of Hannover Medical School under protocol number 12414-BO-S-2026, incorporating strict data trustee safeguards to ensure that sensitive clinical and billing identifiers remain securely pseudonymized during record linkage. Although the authors note that provider recruitment across busy clinical practices represents a potential operational challenge, the planned combination of multi-channel outreach, institutional network endorsement, and standardized electronic data collection provides a resilient operational framework. Ultimately, the empirically grounded consensus recommendations generated by the ACTION study are intended to support the nationwide integration of cooperative, interdisciplinary aftercare pathways, improving access, communication, and long-term surveillance quality for cancer survivors regardless of geographic proximity to tertiary specialized centers.

Subject of Research: Protocol for a mixed-methods study evaluating general practitioner involvement in oncological aftercare

Article Title: General practitioners’ involvement in oncological aftercare (ACTION): a study protocol for a mixed-methods study

Article References: van Baal, K., Stiel, S., Arendt, S., Münte, C., & Klemmt, M. (2026). General practitioners’ involvement in oncological aftercare (ACTION): a study protocol for a mixed-methods study. BMC Primary Care, 27(1), Article 369. https://doi.org/10.1186/s12875-026-03603-z

Image Credits: AI Generated

DOI: 10.1186/s12875-026-03603-z

Keywords: cancer aftercare, general practice, oncology, health services research, mixed methods, cancer survivorship, routine health data, Delphi consensus, General, practitioners, involvement, oncological

News Source: Nathaniel Bowman. (November 10, 2026). Mixed-Methods ACTION Study Evaluates General Practitioners in German Cancer Aftercare. Scienmag.

Tags: cancer aftercarecancer survivorshipDelphi Consensusgeneralgeneral practicehealth services researchinvolvementmixed methodsoncologicalOncologypractitionersroutine health data
Share12Tweet7Share2ShareShareShare1

Related Posts

Multidisciplinary Hospital Program Linked to Lower Enteral Nutrition Diarrhea Rates

Multidisciplinary Hospital Program Linked to Lower Enteral Nutrition Diarrhea Rates

November 16, 2026
Combat sports safeguarding extends beyond violence to health risks

Combat sports safeguarding extends beyond violence to health risks

November 16, 2026

Preterm Infants Born to Mothers With Preeclampsia Show Elevated Oxidative Protein Markers

November 16, 2026

Dogs with azotemia show higher cholesterol, triglycerides, and LDL

November 16, 2026

POPULAR NEWS

  • Single-Cell Sequencing Unveils Immune Signatures Linked to Methotrexate Response in Arthritis

    Single-Cell Sequencing Unveils Immune Signatures Linked to Methotrexate Response in Arthritis

    29 shares
    Share 12 Tweet 7
  • CRISPR Gene Editing Yields Non-Browning Bananas to Extend Shelf Life

    29 shares
    Share 12 Tweet 7
  • Rare Pannonibacter Bloodstream Infection in Hemodialysis Patient Resolves After Catheter Removal

    29 shares
    Share 12 Tweet 7
  • Machine Learning Distinguishes Fenugreek Seeds but Exposes Deep Learning Context Flaws

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Multidisciplinary Hospital Program Linked to Lower Enteral Nutrition Diarrhea Rates

Combat sports safeguarding extends beyond violence to health risks

Network Embedding Reveals Severity Modules in Rare PMM2-CDG Cohort

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.